Dr Youry Kim
Clinical (Tutor)
Department of Infectious Diseases
17 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Methaneseleninic acid, a circadian-modulating agent, reactivates latent HIV-1 infection without cellular activation or proliferation
DOI: 10.1128/jvi.01983-252026
Journal article
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir
DOI: 10.1371/journal.ppat.10139232025
Journal article
Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
DOI: 10.1016/j.jviromet.2025.1152362025
Journal article
Host-directed approaches in the pursuit of a cure for HIV
DOI: 10.1016/j.antiviral.2025.1062162025
Journal article
Efficient mRNA delivery to resting T cells to reverse HIV latency
DOI: 10.1038/s41467-025-60001-22025
Journal article
Targeting Ikaros and Aiolos with pomalidomide fails to reactivate or induce apoptosis of the latent HIV reservoir
DOI: 10.1128/jvi.01676-242021
Research Grant
Combining Pro-Apoptotic Drugs With Latency Reversing Agents to Kill HIV Latently Infected Cells
RECENT SCHOLARLY WORKS
2023
Journal article
Venetoclax, alone and in combination with the BH3 mimetic S63845, depletes HIV-1 latently infected cells and delays rebound in humanized mice
DOI: 10.1016/j.xcrm.2023.1011782023
Journal article
Adaptation of Droplet Digital PCR-Based HIV Transcription Profiling to Digital PCR and Association of HIV Transcription and Total or Intact HIV DNA
DOI: 10.3390/v150716062023
Journal article
Adaptation of the intact proviral DNA assay to a nanowell-based digital PCR platform
DOI: 10.1016/j.jve.2023.1003352022
Journal article
OP 1.8 – 00204 Romidepsin in combination with the BCL-2 antagonist venetoclax synergistically reduce the size of the HIV reservoir
DOI: 10.1016/j.jve.2022.100103